drug · small molecule
dronabinol
Marketedupdated 3mo agoby Vertanical GmbH🔗 ChEMBL
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 5Small molecule drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 32 investigational indications.
indications
investigational
Alzheimer's DiseaseParkinson's Disease
targets
Cannabinoid receptor 1
all catalysts(1)
Trials studying dronabinol
- phase3RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSA
- phase3To Evaluate the Efficacy, Safety, and Tolerability of Dronabinol Oral Solution for Agitation in Patients With Alzheimer's Disease
- phase3Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer
- phase1Bioavailability, Bioequivalence and Tolerability of IHL-42X Compared to the Reference Drugs
Patent cliff
source: FDA Orange Bookfirst barrier falls
Aug 6, 2028
~2.0 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (4)
- Aug 6, 2028compositionUS 102652932.0y
- Aug 6, 2028compositionUS 112534722.0y
- Aug 6, 2028compositionUS 82222922.0y
- Aug 6, 2028compositionUS 93457712.0y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 58m ago
Found something off?
comments(0)
5-min edit window · permanent after that